![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/10/2895990/0/en/Presentation-at-the-Society-of-Nuclear-Medicine-Molecular-Imaging-SNMMI-2024-Annual-Meeting-Highlights-Ashvattha-Product-Candidates-for-Neuroinflammation-Imaging-and-Treatment.html
https://www.globenewswire.com/news-release/2024/05/23/2887262/0/en/Ashvattha-Therapeutics-to-Present-Preclinical-Data-at-the-CMSC-and-SNMMI-Annual-Meetings.html
https://www.globenewswire.com//news-release/2024/02/22/2833676/0/en/Ashvattha-Therapeutics-Announces-First-Patient-Enrolled-in-Expanded-Phase-1-2-Study-of-Imaging-Agent-18F-OP-801-in-Additional-Neurological-Indications.html
https://www.globenewswire.com//news-release/2024/02/14/2829078/0/en/Ashvattha-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/01/04/2803993/0/en/Ashvattha-Therapeutics-Announces-the-Appointment-of-Mehdi-Paborji-as-Senior-Vice-President-of-Technical-Operations.html
https://www.globenewswire.com/news-release/2023/11/20/2783236/0/en/Ashvattha-Therapeutics-to-Participate-in-Upcoming-Ophthalmology-Conferences.html
https://www.globenewswire.com//news-release/2023/11/01/2771178/0/en/Ashvattha-Therapeutics-Announces-First-Patient-Dosed-via-Subcutaneous-Administration-of-Anti-Angiogenic-Therapeutic-D-4517-2-for-Wet-AMD-and-DME-in-Phase-2-Chronic-Dosing-Study.html
https://www.globenewswire.com//news-release/2023/10/09/2756666/0/en/Ashvattha-Therapeutics-Announces-Appointment-of-Dr-Sakura-Minami-as-Vice-President-of-Translational-Medicine-and-Nonclinical-Development-and-Sarah-Thayer-as-Head-of-Clinical-Operat.html
https://www.globenewswire.com//news-release/2023/08/22/2729494/0/en/Ashvattha-Therapeutics-Presents-Promising-Preclinical-Data-on-New-Dendranib-Nanomedicine-Candidate-ASH41020-at-the-16th-International-Society-of-Neuroimmunology-Congress-ISNI.html
https://www.globenewswire.com/news-release/2023/08/15/2725465/0/en/Ashvattha-Therapeutics-Announces-Poster-Presentation-of-Preclinical-Data-on-New-Dendranib-Nanomedicine-Candidate-at-the-16th-International-Society-of-Neuroimmunology-Congress-ISNI.html